Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC BIOSCIENCE HOLDING A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   20.6% 19.3% 19.0% 0.9% 3.1% 1.3% 4.0% 3.9%   Credit score (0-100)   6 6 6 90 56 80 50 50   Credit rating   B B B A BBB A BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 13.5 0.0 9.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   226 238 225 294 190 527 527 527   Gross profit   226 238 225 296 132 466 0.0 0.0   EBITDA   111 79.6 37.4 51.0 -17.6 198 0.0 0.0   EBIT   111 79.6 37.4 51.0 -17.6 198 0.0 0.0   Pre-tax profit (PTP)   111.0 79.6 37.4 51.6 -21.2 209.8 0.0 0.0   Net earnings   111.0 79.6 37.4 51.6 12.3 170.8 0.0 0.0   Pre-tax profit without non-rec. items   111 79.6 37.4 51.6 -21.2 210 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 76.1 78.8 75.2 0.0 0.0   Shareholders equity total   283 137 57.8 61.6 44.1 231 217 217   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0.0 0.0 0.0 228 289 720 217 217   Net Debt   0.0 0.0 0.0 -60.6 -81.9 -455 -213 -213     See the entire balance sheet 1.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   226 238 225 294 190 527 527 527   Net sales growth   0.0% 5.2% -5.4% 30.6% -35.2% 176.9% 0.0% 0.0%   Gross profit   226 238 225 296 132 466 0.0 0.0   Gross profit growth   0.0% 5.2% -5.4% 31.6% -55.3% 251.6% -100.0% 0.0%   Employees   188 219 151 168 171 176 0 0   Employee growth %   17.5% 16.5% -31.1% 11.3% 1.8% 2.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 0 228 289 720 217 217   Balance sheet change%   -100.0% 0.0% 0.0% 0.0% 26.4% 149.6% -69.9% 0.0%   Added value   111.0 79.6 37.4 51.0 -17.6 197.7 0.0 0.0   Added value %   49.1% 33.5% 16.6% 17.3% -9.3% 37.5% 0.0% 0.0%   Investments   -112 0 0 85 2 -8 -75 0   Net sales trend   0.0 1.0 -1.0 1.0 -1.0 1.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   49.1% 33.5% 16.6% 17.3% -9.3% 37.5% 0.0% 0.0%   EBIT %   49.1% 33.5% 16.6% 17.3% -9.3% 37.5% 0.0% 0.0%   EBIT to gross profit (%)   49.1% 33.5% 16.6% 17.2% -13.3% 42.5% 0.0% 0.0%   Net Earnings %   49.1% 33.5% 16.6% 17.6% 6.5% 32.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   49.1% 33.5% 16.6% 17.6% 6.5% 32.4% 0.0% 0.0%   Pre tax profit less extraordinaries %   49.1% 33.5% 16.6% 17.6% -11.1% 39.8% 0.0% 0.0%   ROA %   61.5% 0.0% 0.0% 22.6% -5.1% 42.4% 0.0% 0.0%   ROI %   25.2% 18.9% 19.2% 31.9% -13.8% 119.3% 0.0% 0.0%   ROE %   42.6% 18.9% 19.2% 43.2% 23.3% 124.2% 0.0% 0.0%   1.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   50.0% 50.0% 50.0% 26.7% 15.3% 32.1% 100.0% 100.0%   Relative indebtedness %   -125.3% -57.6% -25.7% 56.7% 128.4% 92.8% 0.0% 0.0%   Relative net indebtedness %   -125.3% -57.6% -25.7% 36.1% 85.3% 6.4% -40.3% -40.3%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -119.0% 464.8% -230.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   -0.0 -0.0 -0.0 1.0 0.7 1.2 0.0 0.0   Current Ratio   -0.0 -0.0 -0.0 1.2 0.8 1.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 60.6 81.9 455.4 0.0 0.0   1.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 47.7 40.7 57.4 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 48.9% 83.9% 108.7% 40.3% 40.3%   Net working capital   283.4 137.1 57.8 22.2 -38.6 124.6 0.0 0.0   Net working capital %   125.3% 57.6% 25.7% 7.6% -20.3% 23.6% 0.0% 0.0%   1.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   1 1 1 2 1 3 0 0   Added value / employee   1 0 0 0 -0 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 0 0 0 -0 1 0 0   EBIT / employee   1 0 0 0 -0 1 0 0   Net earnings / employee   1 0 0 0 0 1 0 0